Efficacy and safety comparison of nabpaclitaxel plus s-1 and gemcitabine plus s-1 as first-line chemotherapy for metastatic pancreatic cancer

Objectives The retrospective cohort, single-institution analysis was to compare efficacy and safety of nabpaclitaxel plus S-1 (AS) with gemcitabine plus S-1 (GS) as first-line treatment for metastatic pancreatic cancer

Source: Pancreatology - June 1, 2018 Category: Gastroenterology Authors: Wenhui Lou, Yuhong Zhou, Xi Guo, Yaolin Xu Tags: 8. Pancreatic Cancer I Source Type: research